13 June 2021>: Clinical Research
Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis After Splenectomy
Long Huang ABCEF* , Qingsheng Yu AEF , Hui Peng CDEDOI: 10.12659/MSM.931157
Med Sci Monit 2021; 27:e931157
Table 1 Clinical characteristics of included patients, n (%).
Variable | PVST group (n=30) | Control group (n=20) |
---|---|---|
Sex | ||
Male | 16 (53.3) | 12 (60.0) |
Female | 14 (46.7) | 8 (40.0) |
Age (years, mean±SD) | 30.5±13.5 | 32.9±14.8 |
Degree of splenomegaly | ||
Slight | 12 (40.0) | 9 (45.0) |
Moderate | 11 (36.7) | 8 (40.0) |
Severe | 7 (23.3) | 3 (15.0) |
Child-Pugh grade | ||
Child A | 15 (41.7) | 10 (50.0) |
Child B | 13 (53.3) | 9 (18.0) |
Child C | 2 (5.0) | 1 (5.0) |
Location of thrombus | ||
MPV/PB | 13 (43.3) | NA |
SV | 4 (13.3) | NA |
MPV/PB+SMV | 2 (6.7) | NA |
MPV/PB+SV | 5 (16.7) | NA |
MPV/PB+SMV+SV | 6 (20.0) | NA |
Operation time (min) | 255.5±83.5 | 223.5±75.3 |
Blood loss (ml) | 293.5±180.5 | 275.8±175.6 |
Complication | ||
Bleeding | 1 (3.3) | 1 (5.0) |
Ascites | 4 (13.3) | 1 (5.0) |
Encephalopathy | 0 | 1 (5.0) |
PVST | 30 (100.0) | 0 |
Incisional infection | 1 (3.3) | 1 (5.0) |
PVST – portal vein system thrombosis; MPV/PB – main portal vein/portal branch; SMV – superior mesenteric vein; SV – splenic vein; NA – not applicable. |